AC
Highly rated in
4
conditions
Highly rated in
4
conditions
Check Dr. Andreea Coca's experience treating your condition:
About Dr. Andreea Coca

Andreea Coca is a Rheumatologist and an Allergy and Immunologist in Rochester, New York. Coca has been practicing medicine for over 23 years and is highly rated in 4 conditions, according to our data. Her top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis RA, Interstitial Keratitis, and Eales Disease. She is licensed to treat patients in New York. Coca is currently accepting new patients.

Her clinical research consists of co-authoring 12 peer reviewed articles and participating in 2 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Andreea Coca it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Andreea Coca accepts the following insurance:

  •  Ambetter
Locations
4901 Lac De Ville Blvd, Rochester, NY 14618
Background & Education
Graduate Institution
Other, 1999
Specialties
Rheumatology
Allergy and Immunology
Licenses
Internal Medicine in NY
Hospital Affiliations
UPMC McKeesport
Conemaugh Health System - Conemaugh Memorial Medical Center Main Campus
St Clair Health
Heritage Valley Sewickley
Meadville Medical Center
Uniontown Hospital
UPMC Presbyterian
Penn Highlands Connellsville
Heritage Valley Beaver
UPMC St Margaret
UPMC Magee-Womens Hospital
UPMC Mercy
Languages Spoken
English
Romanian
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors